Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Blood Rev. 2015 Apr 19;29(6):351–357. doi: 10.1016/j.blre.2015.04.001

Table 2.

Barriers to uptake of evidence.

Intervention/ study design based Use of surrogate end-points which may not be clinically relevant
Inconsistent clinical trial results
Complex or costly intervention only available in academic centers or requiring high level of staff expertise
Results not applicable to the general population because of selection bias in the trials
Clinician based Lack of knowledge of evidence
Lack of motivation/ Clinical inertia to change practice
Disagreement with results
Beliefs about lack of feasibility of the intervention
Patient based Preference/ expectations/ knowledge
System based Intervention with difficult logistics
Payer influence/ lack of reimbursement
Lack of incentive to change
Limited availability of resources/ organizational support